The Cyprus Society of Hematology was established in 2008 to serve as a scientific society representing hematologists in the Republic of Cyprus. The society's main objectives are to promote the advancement of hematology in Cyprus through education, research, and collaboration among healthcare professionals in the field.
Recently, they joined the BPDCN International Registry, launched by IMMONC, adding Cyprus to the list of collaborating countries for BPDCN.
About the BPDCN International Registry
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy discovered in 2008. The International Registry is a multicenter, international prospective and retrospective registry with the aim of collecting data of patients with a diagnosis of BPDCN globally. If you think your hospital would benefit from partnership in this registry, please contact Dr.Astghik Voskanyan ([email protected]).
About IMMONC
Immune Oncology Research Institute (IMMONC) is dedicated to advancing research aimed at preventing, treating, and ultimately curing cancer while making these innovations accessible to those who need them. If you're interested in joining our team, please feel free to contact us at [email protected] or at +374-41 310-048.